Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder

Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder

(2020) Sarah Kittel-Schneider et al.   Frontiers in Psychiatry

Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey

(2020) Leona Bessonova et al.   BMC Psychiatry

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

(2018) Lakshmi N Yatham et al.   BIPOLAR DISORDERS

Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity

(2018) Sadiya S. Khan et al.   JAMA Cardiology

Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder

(2017) Mallik Greene et al.   JOURNAL OF MEDICAL ECONOMICS

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

(2017) Marco Solmi et al.   Therapeutics and Clinical Risk Management

Determinants and Consequences of Obesity

(2016) Adela Hruby et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Identifying Patient Characteristics Associated with High Schizophrenia-Related Direct Medical Costs in Community-Dwelling Patients

(2016) Pooja R. Desai et al.   JOURNAL OF MANAGED CARE PHARMACY

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

(2015) MARC DE HERT et al.   World Psychiatry

Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis

(2014) Maarten Bak et al.   PLoS One

Health Insurance Coverage Among Persons With Schizophrenia in the United States

(2014) Elizabeth Khaykin et al.   PSYCHIATRIC SERVICES

Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions

(2014) Petter Andreas Ringen et al.   Frontiers in Psychiatry

Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database

(2013) Chris J Bushe et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The dietary pattern of patients with schizophrenia: A systematic review

(2012) Salvatore Dipasquale et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Incidence of Schizophrenia and Other Psychoses in England, 1950–2009: A Systematic Review and Meta-Analyses

(2012) James B. Kirkbride et al.   PLoS One

The burden of obesity among adults with bipolar disorder in the United States

(2011) Benjamin I Goldstein et al.   BIPOLAR DISORDERS

Physical health in schizophrenia: a challenge for antipsychotic therapy

(2010) A. Heald   EUROPEAN PSYCHIATRY

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: Effect modification or regression to the mean?

(2009) David B. Allison et al.   PSYCHIATRY RESEARCH

Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality

(2008) J. McGrath et al.   EPIDEMIOLOGIC REVIEWS

Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course

(2008) Stefan Gebhardt et al.   JOURNAL OF PSYCHIATRIC RESEARCH